Cargando…
Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets
Glioblastoma (GBM) is the most common and malignant primary brain cancer in adults. Without treatment the mean patient survival is approximately 6 months, which can be extended to 15 months with the use of multimodal therapies. The low effectiveness of GBM therapies is mainly due to the tumor infilt...
Autores principales: | Erices, José Ignacio, Bizama, Carolina, Niechi, Ignacio, Uribe, Daniel, Rosales, Arnaldo, Fabres, Karen, Navarro-Martínez, Giovanna, Torres, Ángelo, San Martín, Rody, Roa, Juan Carlos, Quezada-Monrás, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139189/ https://www.ncbi.nlm.nih.gov/pubmed/37108208 http://dx.doi.org/10.3390/ijms24087047 |
Ejemplares similares
-
Adapt to Persist: Glioblastoma Microenvironment and Epigenetic Regulation on Cell Plasticity
por: Uribe, Daniel, et al.
Publicado: (2022) -
A(2B) Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New Insights into MRP3 Transporter Function
por: Rocha, José-Dellis, et al.
Publicado: (2022) -
Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness
por: Niechi, Ignacio, et al.
Publicado: (2019) -
The Adenosine A(3) Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia
por: Rocha, René, et al.
Publicado: (2018) -
The low affinity A2B adenosine receptor enhances migratory and invasive capacity in vitro and angiogenesis in vivo of glioblastoma stem-like cells
por: Erices, José I., et al.
Publicado: (2022)